These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3258160)

  • 1. Interleukin 2 production in bone marrow of normal individuals and patients associated with B-cell chronic lymphocytic leukaemia.
    Rossi JF; Klein B; Commes T; Jourdan M; Janbon C
    Br J Haematol; 1988 Feb; 68(2):207-12. PubMed ID: 3258160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine activity after human bone marrow transplantation. III. Defect in IL2 production by peripheral blood mononuclear cells is not corrected by stimulation with Ca++ ionophore plus phorbol ester.
    Cooley MA; McLachlan K; Atkinson K
    Br J Haematol; 1989 Nov; 73(3):341-7. PubMed ID: 2481490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type.
    Rossi JF; Commes T; Grenier J; Jourdan M; Chichehian B; Klein B
    Am J Hematol; 1988 Dec; 29(4):183-8. PubMed ID: 3142255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 2 production in B cell chronic lymphocytic leukemia.
    Rossi JF; Klein B; Commes T; Jourdan M
    Blood; 1985 Oct; 66(4):840-7. PubMed ID: 3876123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proliferative response of B cell chronic lymphocytic leukemia to interleukin 2: functional characterization of the interleukin 2 membrane receptors.
    Touw I; Dorssers L; Löwenberg B
    Blood; 1987 Jun; 69(6):1667-73. PubMed ID: 3107631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of interleukin-2-like material by B-chronic lymphocytic leukemia cells. An autocrine or paracrine model of production and utilization?
    Giovarelli M; Foa R; Benetton G; Lusso P; Fierro MT; Forni G
    Leuk Res; 1988; 12(3):201-9. PubMed ID: 3259277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.
    Wanebo HJ; Pace R; Hargett S; Katz D; Sando J
    Cancer; 1986 Feb; 57(3):656-62. PubMed ID: 3484660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
    Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
    Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood.
    Herndon TM; Chen SS; Saba NS; Valdez J; Emson C; Gatmaitan M; Tian X; Hughes TE; Sun C; Arthur DC; Stetler-Stevenson M; Yuan CM; Niemann CU; Marti GE; Aue G; Soto S; Farooqui MZH; Herman SEM; Chiorazzi N; Wiestner A
    Leukemia; 2017 Jun; 31(6):1340-1347. PubMed ID: 28074063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of chromosomal rearrangements in bone marrow cells and blast transformed B-cells in relapse of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Andreieva SV; Korets KV; Ruzhinska OE; Skorokhod IM; Alkhimova OG
    Exp Oncol; 2017 Jul; 39(2):141-144. PubMed ID: 29483496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restriction of blood and marrow CLL-B cells to free L-chain Ig secretion: implication for normal B-cell function and control.
    Hopper JE; O'Brien J; Papagiannes E
    Am J Hematol; 1988 Nov; 29(3):125-33. PubMed ID: 3142253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of bone marrow involvement in chronic lymphocytic leukemia and small lymphocytic (well differentiated) non-Hodgkin's lymphoma. Its clinical significance in relation to their differential diagnosis and prognosis.
    Pangalis GA; Roussou PA; Kittas C; Mitsoulis-Mentzikoff C; Matsouka-Alexandridis P; Anagnostopoulos N; Rombos I; Fessas P
    Cancer; 1984 Aug; 54(4):702-8. PubMed ID: 6744204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
    Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal T cell colony numbers in untreated patients with chronic lymphocytic leukaemia (CLL).
    Fernandez LA; MacSween JM; Langley GR
    Br J Haematol; 1984 May; 57(1):97-104. PubMed ID: 6609714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia.
    Frankel AE; Fleming DR; Hall PD; Powell BL; Black JH; Leftwich C; Gartenhaus R
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3555-61. PubMed ID: 14506141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHA/IL2: an efficient mitogen cocktail for cytogenetic studies of non-Hodgkin lymphoma and chronic lymphocytic leukemia.
    Morgan R; Chen Z; Richkind K; Roherty S; Velasco J; Sandberg AA
    Cancer Genet Cytogenet; 1999 Mar; 109(2):134-7. PubMed ID: 10087947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and production of interleukin 4 in B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Proctor SJ; Miller S; Dickinson AM
    Leuk Lymphoma; 2001 Aug; 42(4):689-98. PubMed ID: 11697499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional heterogeneity of B-CLL lymphocytes: dissociated responsiveness to growth factors and distinct requirements for a first activation signal.
    Karray S; Merle-Béral H; Vazquez A; Gerard JP; Debre P; Galanaud P
    Blood; 1987 Oct; 70(4):1105-10. PubMed ID: 3115334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin 2: evidence of in vivo lymphokine activated killer cell generation.
    Foa R; Guarini A; Gillio Tos A; Cardona S; Fierro MT; Meloni G; Tosti S; Mandelli F; Gavosto F
    Cancer Res; 1991 Feb; 51(3):964-8. PubMed ID: 1988139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.